MDCorp (MDCX) P/S (2016 - 2026)
MDCorp (MDCX) P/S from Feb 3, 2016 to Jul 21, 2026. The TTM MDCorp (MDCX) P/S is 140.97. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of MDCorp (MDCX)
| Year | P/S | Change |
|---|---|---|
| 2026 | 140.97 | -81.70% |
| 2025 | 770.39 | -19.51% |
| 2024 | 957.15 | +5384.32% |
| 2018 | 17.45 | +616.42% |
| 2017 | 2.44 | +346.67% |
| 2016 | 0.55 | N/A |
Comparison MDCorp (MDCX) P/S with competitors
MDCorp (MDCX) P/S is 140.97.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -99.59% |
| NVO | Novo Nordisk | 0.66 | -99.53% |
| GRFS | Grifols SA | 0.67 | -99.52% |
| AMRN | Amarin Corp | 1.39 | -99.01% |
| SCLX | Scilex Holding Company | 1.92 | -98.64% |
| SNY | Sanofi | 2.18 | -98.45% |
| PFE | Pfizer Inc | 2.18 | -98.45% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -98.30% |
| BIIB | Biogen Inc | 2.93 | -97.92% |
| GSK | GSK Plc | 3.22 | -97.71% |
| MRK | Merck & Co Inc | 4.54 | -96.78% |
| AZN | Astrazeneca plc | 4.58 | -96.75% |
| NVS | Novartis AG | 5.07 | -96.40% |
| AMGN | AMGEN Inc | 5.15 | -96.35% |
| GILD | Gilead Sciences Inc | 5.43 | -96.15% |
| JNJ | Johnson & Johnson | 6.34 | -95.50% |
| ABBV | Abbvie Inc | 7.15 | -94.93% |
| LLY | Lilly(Eli) & Company | 14.28 | -89.87% |